Answer
Yes, ranolazine (Ranexa) is contraindicated in patients with moderate or severe liver impairment.
Sources for this answer
- Ranexa 375 mg Prolonged-release tabletA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §4.3 Contraindications · Version 20Document updated
Sources checked